Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

Assessing remission in clinical practice.

Mierau M, Schoels M, Gonda G, Fuchs J, Aletaha D, Smolen JS.

Rheumatology (Oxford). 2007 Jun;46(6):975-9. Epub 2007 Mar 6.

PMID:
17341506
2.

Comparison of three rheumatoid arthritis disease activity scores in clinical routine.

Rintelen B, Sautner J, Haindl PM, Andel I, Maktari A, Leeb BF.

Scand J Rheumatol. 2009;38(5):336-41. doi: 10.1080/03009740902932835.

PMID:
19585379
3.

Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.

Klarenbeek NB, Koevoets R, van der Heijde DM, Gerards AH, Ten Wolde S, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Oct;70(10):1815-21. doi: 10.1136/ard.2010.149260. Epub 2011 Aug 3.

PMID:
21813548
4.

Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.

Wechalekar MD, Lester S, Proudman SM, Cleland LG, Whittle SL, Rischmueller M, Hill CL.

Arthritis Rheum. 2012 May;64(5):1316-22. doi: 10.1002/art.33506.

6.

A simplified disease activity index for rheumatoid arthritis for use in clinical practice.

Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, van Riel PL, Tugwell P.

Rheumatology (Oxford). 2003 Feb;42(2):244-57.

PMID:
12595618
8.
9.

Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?

Linde L, Sørensen J, Østergaard M, Hørslev-Petersen K, Hetland ML.

J Rheumatol. 2010 Feb;37(2):285-90. doi: 10.3899/jrheum.090898. Epub 2010 Jan 15.

PMID:
20080905
10.

American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints.

Kaneko Y, Kondo H, Takeuchi T.

J Rheumatol. 2013 Aug;40(8):1254-8. doi: 10.3899/jrheum.130166. Epub 2013 Jun 15.

PMID:
23772077
11.

Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.

Castrejón I, Dougados M, Combe B, Guillemin F, Fautrel B, Pincus T.

J Rheumatol. 2013 Apr;40(4):386-93. doi: 10.3899/jrheum.121059. Epub 2013 Feb 1.

PMID:
23378463
12.

Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis.

Heiberg T, Kvien TK, Mowinckel P, Aletaha D, Smolen JS, Hagen KB.

Ann Rheum Dis. 2008 Jul;67(7):967-71. Epub 2007 Oct 26.

PMID:
17965118
13.
14.

Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index.

Aletaha D, Martinez-Avila J, Kvien TK, Smolen JS.

Ann Rheum Dis. 2012 Jul;71(7):1190-6. doi: 10.1136/annrheumdis-2012-201491. Epub 2012 Mar 27.

PMID:
22454398
15.
16.

A modified rheumatoid arthritis disease activity score without acute-phase reactants (mDAS28) for epidemiological research.

Bentley MJ, Greenberg JD, Reed GW.

J Rheumatol. 2010 Aug 1;37(8):1607-14. doi: 10.3899/jrheum.090831. Epub 2010 Jul 1.

PMID:
20595282
17.

Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI.

Gaujoux-Viala C, Mouterde G, Baillet A, Claudepierre P, Fautrel B, Le Loët X, Maillefert JF.

Joint Bone Spine. 2012 Mar;79(2):149-55. doi: 10.1016/j.jbspin.2011.04.008. Epub 2011 Jun 15. Review.

PMID:
21680221
18.

Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states.

Aletaha D, Ward MM, Machold KP, Nell VP, Stamm T, Smolen JS.

Arthritis Rheum. 2005 Sep;52(9):2625-36.

19.

Response criteria for rheumatoid arthritis in clinical practice: how useful are they?

Gülfe A, Geborek P, Saxne T.

Ann Rheum Dis. 2005 Aug;64(8):1186-9. Epub 2005 Mar 10.

20.

Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study.

Burmester GR, Ferraccioli G, Flipo RM, Monteagudo-Sáez I, Unnebrink K, Kary S, Kupper H.

Arthritis Rheum. 2008 Jan 15;59(1):32-41. doi: 10.1002/art.23247.

Supplemental Content

Support Center